Rosuvastatin improves myocardial hypertrophy after hemodynamic pressure overload via regulating the crosstalk of Nrf2/ARE and TGF-β/ smads pathways in rat heart-Reference-Cited by-同舟云学术

Rosuvastatin improves myocardial hypertrophy after hemodynamic pressure overload via regulating the crosstalk of Nrf2/ARE and TGF-β/ smads pathways in rat heart

Published:2018-02 Issue: Volume:820 Page:173-182
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Wang Pengbo,Luo Lin,Shen Qiusheng,Shi Gaoyong,Mohammed Anaz,Ni Songshi,Wu Xiang

Funder

Youth Subject of Jiangsu Provincial Commission of Health and Family Planning

Postgraduate Student Research and Practise Innovation Project of Jiangsu Province

Publisher

Elsevier BV

Subject

Pharmacology

Reference41 articles.

1. Nrf2 signaling pathway: pivotal roles in inflammation;Ahmed;Biochim. Et. Biophys. Acta,2017

2. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice;Chanas;Biochem. J.,2002

3. Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy;Chang;Hypertension,2009

4. Inhibition of liver fibrosis by solubilized coenzyme Q10: role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression;Choi;Toxicol. Appl. Pharmacol.,2009

5. Transforming growth factor-beta1 elicits Nrf2-mediated antioxidant responses in aortic smooth muscle cells;Churchman;J. Cell. Mol. Med.,2009

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transforming growth factor-β and bone morphogenetic protein signaling pathways in pathological cardiac hypertrophy;Cell Cycle;2023-11-17

2. SOX4 as a potential therapeutic target for pathological cardiac hypertrophy;European Journal of Pharmacology;2023-11

3. BRD2 protects the rat H9C2 cardiomyocytes from hypoxia‑reoxygenation injury by targeting Nrf2/HO‑1 signaling pathway;Experimental and Therapeutic Medicine;2023-10-04

4. The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells;PLOS ONE;2023-02-08

5. Free radicals, antioxidants, nuclear factor-E2-related factor-2 and liver damage;Vitamins and Hormones;2023